The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review


Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Cholesteatoma


High impact information on Cholesteatoma


Chemical compound and disease context of Cholesteatoma


Biological context of Cholesteatoma


Anatomical context of Cholesteatoma


Gene context of Cholesteatoma


Analytical, diagnostic and therapeutic context of Cholesteatoma


  1. July 2001: 58-year-old man with a temporal bone mass. Havlik, D.M., Hart, B.L., Becher, M.W. Brain Pathol. (2002) [Pubmed]
  2. Expression of matrix-degrading cysteine proteinase cathepsin K in cholesteatoma. Hansen, T., Unger, R.E., Gaumann, A., Hundorf, I., Maurer, J., Kirkpatrick, C.J., Kriegsmann, J. Mod. Pathol. (2001) [Pubmed]
  3. Ceftazidime for therapy of children with chronic suppurative otitis media without cholesteatoma. Arguedas, A.G., Herrera, J.F., Faingezicht, I., Mohs, E. Pediatr. Infect. Dis. J. (1993) [Pubmed]
  4. Cholesterol in cholesteatoma and in the otitis media syndrome. Sadé, J., Teitz, A. The American journal of otology. (1982) [Pubmed]
  5. Fallopian bridge technique in surgery for chronic ear disease. Pensak, M.L., Friedman, R.A. Laryngoscope (1997) [Pubmed]
  6. Production of parathyroid-hormone-related protein by cholesteatoma cells in culture. Cheshire, I.M., Blight, A., Ratcliffe, W.A., Proops, D.W., Heath, D.A. Lancet (1991) [Pubmed]
  7. Possible involvement of keratinocyte growth factor and its receptor in enhanced epithelial-cell proliferation and acquired recurrence of middle-ear cholesteatoma. Yamamoto-Fukuda, T., Aoki, D., Hishikawa, Y., Kobayashi, T., Takahashi, H., Koji, T. Lab. Invest. (2003) [Pubmed]
  8. The effect of cyclophosphamide on development of experimental cholesteatoma. Pownell, P.H., Wright, C.G., Robinson, K.S., Meyerhoff, W.L. Arch. Otolaryngol. Head Neck Surg. (1994) [Pubmed]
  9. Expression of involucrin in human middle ear cholesteatoma. Chao, W.Y., Huang, C.C. The American journal of otology. (1989) [Pubmed]
  10. The topical use of 5-fluorouracil in the ear in the management of cholesteatoma and excessive mucous secretion. Smith, M.F. Laryngoscope (1985) [Pubmed]
  11. Prevention of recurrent cholesteatoma: use of hydroxyapatite plates and composite grafts. Black, B. The American journal of otology. (1992) [Pubmed]
  12. Determination of the levels of expression of sarcolectin and calcyclin and of the percentages of apoptotic but not proliferating cells to enable distinction between recurrent and nonrecurrent cholesteatomas. Choufani, G., Mahillon, V., Decaestecker, C., Lequeux, T., Danguy, A., Salmon, I., Gabius, H.J., Hassid, S., Kiss, R. Laryngoscope (1999) [Pubmed]
  13. Molecular biological diagnosis of congenital and acquired cholesteatoma on the basis of differences in telomere length. Kojima, H., Miyazaki, H., Shiwa, M., Tanaka, Y., Moriyama, H. Laryngoscope (2001) [Pubmed]
  14. Kinetic analysis of cell proliferation using bromodeoxyuridine labeling and in situ detection of dying cells in the tympanic membrane and middle ear cholesteatoma. Koba, R., Yagi, M., Tabe, H., Kawabata, I. Arch. Histol. Cytol. (1996) [Pubmed]
  15. Keratin particle-induced osteolysis: a mouse model of inflammatory bone remodeling related to cholesteatoma. Chole, R.A., Hughes, R.M., Faddis, B.T. J. Assoc. Res. Otolaryngol. (2001) [Pubmed]
  16. Expression of p53 protein in human middle ear cholesteatomas: pathogenetic implications. Albino, A.P., Reed, J.A., Bogdany, J.K., Sassoon, J., Desloge, R.B., Parisier, S.C. The American journal of otology. (1998) [Pubmed]
  17. Effect of intratympanic steroid application on the development of experimental cholesteatoma. Sennaroglu, L., Ozkul, A., Gedikoglu, G., Turan, E. Laryngoscope (1998) [Pubmed]
  18. Quantitative analysis of interleukin-1-alpha gene expression in middle ear cholesteatoma. Bujía, J., Kim, C., Boyle, D., Hammer, C., Firestein, G., Kastenbauer, E. Laryngoscope (1996) [Pubmed]
  19. Imaging cholesteatoma. Phelps, P.D., Wright, A. Clinical radiology. (1990) [Pubmed]
  20. Possible role of interleukin 1 alpha and interleukin 1 beta in the pathogenesis of cholesteatoma of the middle ear. Schilling, V., Negri, B., Bujía, J., Schulz, P., Kastenbauer, E. The American journal of otology. (1992) [Pubmed]
  21. Expression of transforming growth factor-alpha and epidermal growth factor receptor in middle ear cholesteatoma. Ergün, S., Zheng, X., Carlsöö, B. The American journal of otology. (1996) [Pubmed]
  22. Roles of cytokines and cell cycle regulating substances in proliferation of cholesteatoma epithelium. Tanaka, Y., Kojima, H., Miyazaki, H., Koga, T., Moriyama, H. Laryngoscope (1999) [Pubmed]
  23. A comparative immunohistochemical study of cytokeratin and vimentin expression in middle ear mucosa and cholesteatoma, and in epidermis. Broekaert, D., Cornille, A., Eto, H., Leigh, I., Ramaekers, F., Van Muijen, G., Coucke, P., De Bersaques, J., Kluyskens, P., Gillis, E. Virchows Archiv. A, Pathological anatomy and histopathology. (1988) [Pubmed]
  24. Terminal differentiation and mitogen-activated protein kinase signaling in human cholesteatoma epithelium. Huisman, M.A., De Heer, E., Grote, J.J. Otol. Neurotol. (2006) [Pubmed]
  25. Outpatient management of chronic suppurative otitis media without cholesteatoma in children. Dagan, R., Fliss, D.M., Einhorn, M., Kraus, M., Leiberman, A. Pediatr. Infect. Dis. J. (1992) [Pubmed]
  26. Cytokeratins in induced epidermoid formations and cholesteatoma lesions. Vennix, P.P., Kuijpers, W., Tonnaer, E.L., Peters, T.A., Ramaekers, F.C. Arch. Otolaryngol. Head Neck Surg. (1990) [Pubmed]
  27. Evaluation of epidermal hyperproliferation in patients with cholesteatoma. Aberg, B., Edström, S., Johannesson, A., Larkö, O. The American journal of otology. (1991) [Pubmed]
  28. Profile of anti-stratum corneum autoantibodies in patients with aural cholesteatoma. Bujía, J., Stammberger, M., Holly, A., Kastenbauer, E. The American journal of otology. (1994) [Pubmed]
WikiGenes - Universities